Current available therapies and future directions in the treatment of malignant gliomas
Annick Desjardins1,2, David A Reardon1,3, James J Vredenburgh1,21The Preston Robert Tisch Brain Tumor Center; 2Department of Medicine; 3Department of Surgery, Duke University Medical Center, Durham, NC, USAAbstract: The prognosis of patients diagnosed with malignant glioma (MG) remains poor. However...
Saved in:
Main Authors: | Annick Desjardins, David A Reardon, James J Vredenburgh |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/f28bd4fe4a054f819c5dc43eb35249c7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Galectins in Glioma: Current Roles in Cancer Progression and Future Directions for Improving Treatment
by: Samy Ajarrag, et al.
Published: (2021) -
Regenerative nanomedicine: current perspectives and future directions
by: Chaudhury K, et al.
Published: (2014) -
Magnetic particle imaging: current developments and future directions
by: Panagiotopoulos N, et al.
Published: (2015) -
Nanotherapeutics in the EU: an overview on current state and future directions
by: Hafner A, et al.
Published: (2014) -
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles
by: Orza A, et al.
Published: (2013)